CD4 and chronic graft versus host disease: In the research conducted by K. Jimbo and colleagues, it was observed that there was a significant increase in CD4+ Tscm (T stem cells) in patients with chronic graft-versus-host disease (cGVHD) following allogeneic hematopoietic cell transplantation.